274 да са по- чести при пациенти с хроничен хепатит С, такива има и при пациенти с онкологични заболявания, лекувани с интерферон алфа.
While this has been reported more often in patients with chronic hepatitis C treated with interferon alpha, it has also been reported in patients with oncologic diseases treated with interferon alpha.